TGTB227 is a human monoclonal antibody (mAb) targeting TIGIT. It works by reducing Foxp3 expression in regulatory T cells (Tregs), thereby inhibiting their immunosuppressive function. TGTB227 is applicable for research in tumor immunology.
Target:
Others
* VAT and and shipping costs not included. Errors and price changes excepted
